224 related articles for article (PubMed ID: 16940119)
21. Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes.
Ardanuy C; Tubau F; Liñares J; Domínguez MA; Pallarés R; Martín R;
Antimicrob Agents Chemother; 2005 Feb; 49(2):827-9. PubMed ID: 15673780
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility and molecular epidemiology of Streptococcus pneumoniae isolated from Shanghai, China.
Yang F; Xu XG; Yang MJ; Zhang YY; Klugman KP; McGee L
Int J Antimicrob Agents; 2008 Nov; 32(5):386-91. PubMed ID: 18723327
[TBL] [Abstract][Full Text] [Related]
23. Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy.
Monaco M; Camilli R; D'Ambrosio F; Del Grosso M; Pantosti A
J Antimicrob Chemother; 2005 Feb; 55(2):256-9. PubMed ID: 15649990
[TBL] [Abstract][Full Text] [Related]
24. Erythromycin resistance caused by erm(A) subclass erm(TR) in a Danish invasive pneumococcal isolate: are erm(A) pneumococcal isolates overlooked?
Lambertsen L; Ekelund K; Hansen DS; Kaltoft M; Christensen JJ; Hammerum AM
Scand J Infect Dis; 2008; 40(6-7):584-7. PubMed ID: 18584554
[TBL] [Abstract][Full Text] [Related]
25. Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites.
Amezaga MR; Carter PE; Cash P; McKenzie H
J Clin Microbiol; 2002 Sep; 40(9):3313-8. PubMed ID: 12202572
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene.
Dobay O; Rozgonyi F; Amyes SG
Int J Antimicrob Agents; 2005 Jun; 25(6):488-95. PubMed ID: 15878263
[TBL] [Abstract][Full Text] [Related]
27. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
Bejuk D
Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
[TBL] [Abstract][Full Text] [Related]
28. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005.
Wolter N; von Gottberg A; du Plessis M; de Gouveia L; Klugman KP;
Int J Antimicrob Agents; 2008 Jul; 32(1):62-7. PubMed ID: 18339522
[TBL] [Abstract][Full Text] [Related]
29. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
Picazo JJ
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
[TBL] [Abstract][Full Text] [Related]
30. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
[TBL] [Abstract][Full Text] [Related]
31. Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
Xu X; Cai L; Xiao M; Kong F; Oftadeh S; Zhou F; Gilbert GL
Antimicrob Agents Chemother; 2010 Mar; 54(3):1152-9. PubMed ID: 20065057
[TBL] [Abstract][Full Text] [Related]
32. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
[TBL] [Abstract][Full Text] [Related]
33. [Resistance to erythromycin in Streptococcus pneumoniae].
García-Arenzana JM; Montes M; Gómez N; Pérez-Trallero E
Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):613-8. PubMed ID: 1822151
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic susceptibility and molecular epidemiology of nasopharyngeal pneumococci from Spanish children.
Sánchez-Tatay D; Arroyo LA; Tarragó D; Lirola MJ; Porras A; Fenoll A; Hausdorff WP; Brueggemann AB; Obando I
Clin Microbiol Infect; 2008 Aug; 14(8):797-801. PubMed ID: 18727804
[TBL] [Abstract][Full Text] [Related]
35. Macrolide resistance in Streptococcus pneumoniae in Hong Kong.
Ip M; Lyon DJ; Yung RW; Chan C; Cheng AF
Antimicrob Agents Chemother; 2001 May; 45(5):1578-80. PubMed ID: 11302833
[TBL] [Abstract][Full Text] [Related]
36. Recombination rates of Streptococcus pneumoniae isolates with both erm(B) and mef(A) genes.
Lee JY; Song JH; Ko KS
FEMS Microbiol Lett; 2010 Aug; 309(2):163-9. PubMed ID: 20618866
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I).
Cochetti I; Vecchi M; Mingoia M; Tili E; Catania MR; Manzin A; Varaldo PE; Montanari MP
Antimicrob Agents Chemother; 2005 Dec; 49(12):4999-5006. PubMed ID: 16304164
[TBL] [Abstract][Full Text] [Related]
38. Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era.
Daikos GL; Koutsolioutsou A; Tsiodras S; Theodoridou M; Koutouzis EI; Charissiadou A; Pangalis A; Michos AG; Chaidopoulou F; Braoudaki M; Syriopoulou VP
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):393-8. PubMed ID: 18077121
[TBL] [Abstract][Full Text] [Related]
39. Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004).
Cantón R; Unal S; Farrell DJ
Int J Antimicrob Agents; 2007 Dec; 30(6):546-50. PubMed ID: 17931834
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey.
Sener B; Köseoglu O; Gür D; Bryskier A
J Chemother; 2005 Feb; 17(1):31-5. PubMed ID: 15828441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
